Abstract:Biophysical and structural investigations are presented with a focus on the membrane lipid interactions of cationic linear antibiotic peptides such as magainin, PGLa, LL37, and melittin. Observations made with these peptides are distinct as seen from data obtained with the hydrophobic peptide alamethicin. The cationic amphipathic peptides predominantly adopt membrane alignments parallel to the bilayer surface; thus the distribution of polar and non-polar side chains of the amphipathic helices mirror the environmental changes at the membrane interface. Such a membrane partitioning of an amphipathic helix has been shown to cause considerable disruptions in the lipid packing arrangements, transient openings at low peptide concentration, and membrane disintegration at higher peptide-to-lipid ratios. The manifold supramolecular arrangements adopted by lipids and peptides are represented by the 'soft membranes adapt and respond, also transiently' (SMART) model. Whereas molecular dynamics simulations provide atomistic views on lipid membranes in the presence of antimicrobial peptides, the biophysical investigations reveal interesting details on a molecular and supramolecular level, and recent microscopic imaging experiments delineate interesting sequences of events when bacterial cells are exposed to such peptides. Finally, biophysical studies that aim to reveal the mechanisms of synergistic interactions of magainin 2 and PGLa are presented, including unpublished isothermal titration calorimetry (ITC), circular dichroism (CD) and dynamic light scattering (DLS) measurements that suggest that the peptides are involved in liposome agglutination by mediating intermembrane interactions. A number of structural events are presented in schematic models that relate to the antimicrobial and synergistic mechanism of amphipathic peptides when they are aligned parallel to the membrane surface.

Differences in Relevant Physicochemical Properties Correlate with Synergistic Activity of Antimicrobial Peptides

Understanding Antimicrobial Peptide Synergy: Differential Binding Interactions and Their Impact on Membrane Integrity

Antimicrobial Peptide Synergies for Fighting Infectious Diseases

Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions

On the Aggregation State of Synergistic Antimicrobial Peptides

Physicochemical Features and Peculiarities of Interaction of Antimicrobial Peptides with the Membrane

Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections

Emergent conformational and aggregation properties of synergistic antimicrobial peptide combinations

Transmembrane and Antimicrobial Peptides. Hydrophobicity, Amphiphilicity and Propensity to Aggregation

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure

AMP-Mimetic Antimicrobial Polymer-Involved Synergic Therapy with Various Coagents for Improved Efficiency

Diversity and Mechanisms of Action of Plant, Animal, and Human Antimicrobial Peptides

Improving the Activity of Antimicrobial Peptides Against Aquatic Pathogen Bacteria by Amino Acid Substitutions and Changing the Ratio of Hydrophobic Residues

Potent Activity of Hybrid Arthropod Antimicrobial Peptides Linked by Glycine Spacers

Relationship Between Peptide Structure and Antimicrobial Activity As Studied by De Novo Designed Peptides.

Biophysical Investigations Elucidating the Mechanisms of Action of Antimicrobial Peptides and Their Synergism

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial peptides designed by computational analysis of proteomes

Insight into the Structural Requirements of Antimicrobial Peptides by Multiple Validated 3D-QSAR Approaches